Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY) has launched a new pot education platform to provide resources and educate healthcare practitioners and their patients.
This week, the leading cannabis producer with operations worldwide announced its WeCare-MedicalCannabis platform has been launched in Germany, France, the United Kingdom and Portugal.
The free portal is in four languages and goes over the what, when, how, why, who and where of cannabis for the four countries explaining to patients, caregivers and medical practitioners the ins and outs of how to use cannabis for medical purposes safely.
Read more: Tilray Medical expands U.K. portfolio
Read more: Luxembourg health authorities visit Tilray Medical facilities in Portugal
Photo via WeCare-MedicalCannabis platform
“As global pioneers in medical cannabis, we are aware of the lack of access to science-based, medical cannabis education. WeCare-MedicalCannabis was created to bridge that gap and help provide the needed resources to help patients, caregivers, and healthcare professionals with the information they need to make informed decisions on medicinal cannabis,” Tilray Europe managing director Sascha Mielcarek said.
“As cannabis legalization continues to expand across Europe, Tilray Medical is dedicated to help provide informed and trusted guidance for those interested in learning more about medical cannabis.”
Tilray recently expanded its medical cannabis portfolio in the United Kingdom and recently the Luxembourg government visited its facility in Portugal after supply issues were reported last November.
Tilray is one of the first companies to become an approved licensed producer of medical cannabis in Canada to build one of the first GMP-certified cannabis production facilities in Europe, first in Portugal and later in Germany.
Company stock dipped Thursday by 5.31 per cent to $4.81 on the Toronto Securities Exchange.